PTK2 and neoplasm: To assess tumor growth inhibition, we treated NPE-FAK-WT tumor-bearing mice with the individual drugs (VS4718 and trametinib), their combination, and a vehicle control (hydroxypropyl methylcellulose) for two weeks, followed by culling (Figure 3A).